Shaping cancer policy, worldwide
We generate world-leading research to transform how cancer is prevented, diagnosed, and treated — and translate that evidence into lasting policy change.
A message from our director
Cancer is not simply a medical crisis — it is a failure of political will. We have the science. What the world needs now is the courage to act on it.
Professor Richard Sullivan
Director, Institute of Cancer Policy · Professor of Cancer and Global Health, King's College London
Richard's research spans global cancer policy, health systems in conflict settings, and access to cancer care in low- and middle-income countries. He has led Lancet Commissions on global surgery, childhood cancer, and cancer care in Latin America, and advises the WHO, Save the Children, and the National Cancer Grid of India.
Health economics
Pricing mechanisms and reimbursement barriers across 12 EU member states.
Global access
A policy framework for equitable access to radiotherapy in low-resource settings.
Prevention policy
Implementation outcomes across 40 countries since ratification of the WHO Framework Convention on Tobacco Control.
Low- and middle-income countries
More than 70% of cancer deaths occur in low- and middle-income countries, yet most cancer research and policy expertise remains concentrated in the Global North. Our field programmes work directly with health ministries, clinicians, and communities to build systems that last.
Annual flagship report
Our annual report examines the widening divide in cancer outcomes between high- and low-income countries, and sets out a five-point agenda for governments and international bodies.
New research, policy briefings, and event invitations — straight to your inbox.